$AME

AMETEK (AME) Q2 2026 Earnings Call Transcript

AMETEK (AME) reported Q2 2026 net sales of $2.04B, up 15% year over year, with 10% organic growth. Adjusted EPS was $2.09, up 17%, above guidance of $1.96 to $2.00. Total orders were $2.3B, up 28%, backlog $4.11B. Full-year sales guidance rose about 10% and adjusted EPS to $8.20-$8.30.

Original reporting
Published Aug 11, 2026, 5:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 5:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AMETEK (AME) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The combination of higher sales and EPS guidance, record orders/backlog, and improved working capital conversion provides a coherent upside earnings narrative for AMETEK.

02

Market read

Traders can use the raised FY and Q3 adjusted EPS ranges, record orders/book-to-bill, and margin and cash-flow improvements to reassess near-term earnings expectations.

03

What to watch

The text highlights a large acquisition and credit facility renewal, but does not quantify integration risks, customer concentration, or potential margin pressure from input costs.

Relevance 9/10Novelty 9/10Timing: post-earnings call, guidance and capital/credit updates for immediate repricing

Background

AMETEK’s Q2 2026 earnings call covers record orders, margin expansion, free cash flow, and updated full-year guidance plus acquisition and financing updates.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK reported Q2 2026 net sales of $2.04B, adjusted EPS $2.09, and raised full-year sales and EPS guidance.

Expected impact

Bullish bias for near-term trading as raised FY and Q3 EPS ranges confirm demand and margin momentum.

Evidence & confidence

The article discloses multiple decision-relevant datapoints: raised FY sales and adjusted EPS guidance, Q3 EPS guidance, record orders/book-to-bill, and margin and free-cash-flow expansion.

Market effects

Signals continued strength in industrial instrumentation and electronics tied to AI infrastructure, semiconductors, and defense modernization demand.

No specific regional demand signal beyond broad-based growth across AMETEK divisions.

Demand drivers cited (semiconductor manufacturing, hyperscaler data centers, defense modernization) are globally distributed end markets.

Counterpoint

Raised guidance could already be partially priced; investors may focus on acquisition integration and whether synergy assumptions (Indicor) are achievable.

Key entities

  • AMETEK, Inc.

    Reported Q2 2026 results and raised full-year sales and adjusted EPS guidance; discussed Indicor acquisition, margins, and credit facility renewal.

  • Indicor Instrumentation

    Planned acquisition expected to close in the second half of 2026, with management citing cost synergies.

  • Zygo

    AMETEK metrology and optical solutions business referenced as a semiconductor manufacturing growth driver.

  • RTDS Technologies

    AMETEK unit referenced as receiving an order from a data center hyperscaler for real-time digital simulation.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.